Tenet Healthcare/$THC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tenet Healthcare
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Ticker
$THC
Sector
Primary listing
NYSE
Employees
86,240
Headquarters
Website
Tenet Healthcare Metrics
BasicAdvanced
$18B
13.22
$15.65
1.56
-
Price and volume
Market cap
$18B
Beta
1.56
52-week high
$208.25
52-week low
$109.82
Average daily volume
1M
Financial strength
Current ratio
1.709
Quick ratio
1.208
Long term debt to equity
157.685
Total debt to equity
158.697
Interest coverage (TTM)
4.34%
Profitability
EBITDA (TTM)
4,333
Gross margin (TTM)
40.78%
Net profit margin (TTM)
7.17%
Operating margin (TTM)
17.11%
Effective tax rate (TTM)
19.67%
Revenue per employee (TTM)
$240,000
Management effectiveness
Return on assets (TTM)
7.63%
Return on equity (TTM)
29.65%
Valuation
Price to earnings (TTM)
13.218
Price to revenue (TTM)
0.941
Price to book
5.03
Price to tangible book (TTM)
-2.2
Price to free cash flow (TTM)
12.529
Free cash flow yield (TTM)
7.98%
Free cash flow per share (TTM)
16.515
Growth
Revenue change (TTM)
-1.14%
Earnings per share change (TTM)
-41.98%
3-year revenue growth (CAGR)
2.63%
10-year revenue growth (CAGR)
1.65%
3-year earnings per share growth (CAGR)
25.35%
10-year earnings per share growth (CAGR)
39.60%
What the Analysts think about Tenet Healthcare
Analyst ratings (Buy, Hold, Sell) for Tenet Healthcare stock.
Bulls say / Bears say
Adjusted EPS jumped 74% to $4.02 and consolidated adjusted EBITDA margin expanded by 280 basis points to 21.3% in Q2 2025. Management raised full-year 2025 net operating revenue guidance to $20.95–$21.25 billion and adjusted EBITDA guidance to $4.40–$4.54 billion (Investing.com).
The Ambulatory Care segment posted 11% adjusted EBITDA growth with a 39.2% margin in Q2 2025, and same-facility net patient service revenues climbed 7.7%, highlighting strong, high-margin performance at USPI’s outpatient platform (Investing.com).
Tenet lowered its net debt to adjusted EBITDA ratio to 2.45x at June 30, 2025 from 2.54x at December 31, 2024, demonstrating successful deleveraging through divestitures and strong free cash flow (SEC 10-Q).
Same-facility surgical case volumes declined 0.6% and hospital outpatient visits dropped 3.2% in Q2 2025, suggesting potential volume challenges in Tenet’s main operations (SEC 10-Q).
S&P Global Ratings noted that pending health policy changes in the Reconciliation bill could pose reimbursement risks and potentially increase Tenet’s leverage above the current 3.5x threshold (Investing.com).
Labor costs remain high, with salaries, wages and benefits accounting for 41% of net revenues in Q2 2025—just a 140 bps improvement year over year—pointing to ongoing expense pressure (Investing.com).
Data summarised monthly by Lightyear AI. Last updated on 5 Oct 2025.
Tenet Healthcare Financial Performance
Revenues and expenses
Tenet Healthcare Earnings Performance
Company profitability
Tenet Healthcare News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tenet Healthcare stock?
Tenet Healthcare (THC) has a market cap of $18B as of October 24, 2025.
What is the P/E ratio for Tenet Healthcare stock?
The price to earnings (P/E) ratio for Tenet Healthcare (THC) stock is 13.22 as of October 24, 2025.
Does Tenet Healthcare stock pay dividends?
No, Tenet Healthcare (THC) stock does not pay dividends to its shareholders as of October 24, 2025.
When is the next Tenet Healthcare dividend payment date?
Tenet Healthcare (THC) stock does not pay dividends to its shareholders.
What is the beta indicator for Tenet Healthcare?
Tenet Healthcare (THC) has a beta rating of 1.56. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.